Clinical trial
KRN7000 in Treating Patients With Solid Tumors
NCT00003985 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Withdrawn
Key facts
| NCT number | NCT00003985 |
|---|---|
| Title | KRN7000 in Treating Patients With Solid Tumors |
| Official title | Phase I Study of KRN7000 in Patients With Solid Tumor Treated With a Weekly Intravenous Administration Schedule |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | KRN7000 |
| Enrollment | 0 |
| Start date | Sep 1, 1998 |
| First posted | May 25, 2004 |
| Last update posted | Jul 11, 2012 |
| Countries | Austria, Belgium, Denmark, France, Germany, Netherlands, Norway, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: